Executive Director, Microbiology Quality Sterility Assurance

Bristol Myers SquibbPrinceton, NJ
Hybrid

About The Position

The Executive Director, Microbiology Quality Sterility Assurance (MQSA) is a pivotal global leadership role within BMS's Corporate Quality organization. This position brings critical expertise in sterility assurance, microbiological controls, and contamination control strategy across BMS's internal and external commercial and PD manufacturing sites — spanning pharmaceutical, biopharmaceutical, cell therapy and radiopharmaceuticals. This role is responsible for defining, owning, and governing BMS's enterprise-wide Contamination Control Strategy (CCS) as a living, risk-based framework — ensuring alignment with EU GMP Annex 1, FDA, and all applicable global regulatory standards. The Executive Director serves as the global Single Point of Contact (SPOC) for all sterility assurance and microbiology quality matters, partnering with Product Development (PD), Materials Science & Technology (MSAT), Quality, Internal Manufacturing, and External Manufacturing (EXM) to ensure the highest standards of microbiological control are embedded across BMS's manufacturing network. This is a highly strategic and visible role, operating at the intersection of technical excellence, regulatory compliance, contamination control governance, business planning, and people leadership — with significant influence at the senior executive level. The Executive Director is expected to build and lead this newly established central function, establishing it as a center of excellence for CCS and sterility assurance across BMS's global network.

Requirements

  • Bachelor's degree in a Scientific Discipline, preferably in: Microbiology, Life Sciences, or Biological Sciences
  • Significant and progressive experience in aseptic or bioburden control manufacturing environments (production, QA, and/or validation), with demonstrated successful results in an Health Authority-regulated environment (e.g. FDA, MHRA, EMA, TGA)
  • 10+ years of people management experience, with a track record of leading large, globally distributed teams
  • Proven experience in aseptic/sterility assurance across pharmaceutical, biopharmaceutical, medical device industries
  • Experience leading or supporting regulatory inspections and PAIs including direct engagement with Health Authorities (FDA, EMA, MHRA) as the senior technical SME
  • Demonstrated ability to lead through influence in a complex, global matrix organization — driving cross-functional alignment across operations, engineering, regulatory, and PD stakeholders without direct line authority
  • Executive presence with demonstrated ability to communicate and influence at VP/SVP/C-Suite level, both internally and with external regulatory agencies and industry bodies

Nice To Haves

  • Advanced degree (MS, MPhil, PhD, MTD) in one of the following areas: Microbiology, Industrial Microbiology, Clinical Microbiology, Bacterial Toxicology
  • Experience working within or managing CMO partnerships in a quality assurance capacity
  • Experience in due diligence for CMO onboarding and new product launch's
  • Experience with industry standard-setting activities through PDA,ISPE, PhR MA or equivalent organization

Responsibilities

  • Define, own, and drive BMS's Global Sterility & Microbiology Assurance Strategy, ensuring alignment across all manufacturing sites, CMOs, MS&T, GTS and PD partners
  • Serve as the primary executive-level contact for contamination control and sterility assurance across Operations, Engineering, MS&T, and PD
  • Embed control contamination and aseptic assurance strategy and aseptic-by-design principles into future processes and product development programs
  • Lead remediation plans following regulatory observations, ensuring proactive installation of appropriate aseptic assurance standards (QMS and standard work) across the business
  • Champion continuous improvement initiatives including KPI trending and capability development in aseptic and sterility assurance domains and process confirmations
  • Own and periodically review BMS's Global CCS as a living document, ensuring it reflects current regulatory requirements
  • Establish, own, and govern BMS's global sterility/aseptic assurance and CCS performance metrics framework, including KPI definitions, network-level escalation thresholds, trend analysis, and executive-level reporting cadence
  • Support any implementation of BMS's Sterility Assurance Strategy
  • Lead CMO support in establishing and executing annual Contamination Control Strategies (CCS) and Aseptic/Sterility Assurance Roadmaps
  • Partner with CMOs for KPI analysis, trending, escalation, and gap assessments versus BMS standards (GQPs, QMS, FDA Guidance, etc.)
  • Conduct due diligence activities during onboarding of new CMOs.
  • Drive alignment in ways of working and standard operating procedures between all CMO partners in aseptic/sterility assurance subjects
  • Provide deep technical oversight of microbiological controls across pharmaceutical, biopharmaceutical, cell therapy, radiopharmaceutical and drug product manufacturing operations
  • Lead the identification, qualification, and validation of terminal sterilization suppliers
  • Provide expert technical guidance across product design, process controls, and organizational capabilities with a focus on microbiological controls
  • Drive the adoption of advanced analytics, digital environmental monitoring tools, and data-driven risk assessment approaches to enhance contamination surveillance and EM trending across the network
  • Lead or oversee complex cross-site microbiological investigations, CAPA development, and systemic remediation efforts, ensuring robust root cause analysis and sustainable corrective actions
  • Maintain in-depth knowledge of global regulations, guidance documents, and industry best practices related to sterility assurance, including: EU GMP, FDA, WHO, PDA, ASTM, ISPE, PhRMA , and BMS internal standards
  • Support review of regulatory filings related to sterility assurance and microbiology
  • Lead or actively support sterility assurance-related regulatory inspections globally, including direct engagement with FDA, EMA, MHRA, and other Health Authorities
  • Lead assessment and adoption of new or updated regulations (e.g. Annex 1)
  • Ensure CMOs and internal sites maintain inspection readiness at all times
  • Apply understanding of business planning, capital planning, and business case development to help drive aseptic/sterility assurance investment decisions
  • Balance technical, compliance, and business attributes in the decision-making process, demonstrating strong business acumen
  • Proactively engage and align stakeholders, capabilities, and resources to achieve company objectives
  • Support identification of business solutions to enhance aseptic and low-bioburden manufacturing processes, improving robustness and operational efficiency
  • Lead or proactively influence external aseptic/sterility assurance trade associations and industry working groups (e.g., PDA, ISPE, PhRMA)
  • Represent BMS and proactively influence external scientific and regulatory forums, including Health Authority advisory panels and industry standard-setting bodies
  • Adapt and embed emerging best practices and industry innovations into BMS operations
  • Lead, inspire, and develop a high-performing, globally distributed team of sterility assurance and microbiology professionals
  • Build the newly established central MQSA function from the ground up, defining team structure, roles, operating model, and ways of working in partnership with senior leadership
  • Build a septic/ sterility assurance and microbiological capability across the broader BMS organization through delivery of training, coaching, and mentoring programs
  • Develop technical talent pipelines, supporting career growth and succession planning within the Quality function
  • Energize and align cross-functional teams and business partners toward a shared quality vision
  • Foster a culture of contamination prevention, quality ownership, and continuous learning across all sites and functions within the MQSA community of practice

Benefits

  • Health Coverage: Medical, pharmacy, dental, and vision care.
  • Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
  • Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
  • Work-life benefits include: Paid Time Off US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
  • Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
  • Based on eligibility, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
  • All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service